Ω-3 polyunsaturated fatty acid supplementation does not influence body composition, insulin resistance, and lipemia in women with type 2 diabetes and obesity

Nutrition in Clinical Practice

Volumn 27, Issue 4, 2012, Pages 553-560

  Crochemore, Izabella Candido Carvalho ^a   Souza, Aline F P ^a   De Souza, Andressa C F ^a   Rosado, Eliane Lopes ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

body composition; diabetes mellitus; diabetes mellitus, type 2; fatty acids, 3; hyperlipidemias; insulin resistance

Indexed keywords

DOCOSAPENTAENOIC ACID; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; OMEGA 3 FATTY ACID; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERVENTION STUDY; LIPID METABOLISM; LONGITUDINAL STUDY; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; FEMALE; FISH OILS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; INSULIN; INSULIN RESISTANCE; INTERVENTION STUDIES; MIDDLE AGED; OBESITY; SINGLE-BLIND METHOD; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84864193051     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533612444535     Document Type: Article

References (49)

1. Berdanier CD. Diabetes and nutrition: the mitochondrial part. J Nutr. 2001 ; 131: S344 - S353
2. The World Health Report 2003. Geneva, Switzerland: World Health Organization ; 2003 :
3. Malerbi DA, Franco LJ. Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. Diabetes Care. 1992 ; 15: 1509-1516
4. Consenso Brasileiro de Diabetes. Diagnóstico e classificação do diabetes mellitus e tratamento do diabetes mellitus do tipo II. Rio de Janeiro, Brasil: Sociedade Brasileira de Diabetes ; 2002 :
5. Walker KZ, O'Dea K, Gomez M, Girgis S, Colagiuri R. Diet and exercise in the prevention of diabetes. J Hum Nutr Diet. 2010 ; 23: 344-352
6. IV Diretrizes Brasileiras sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2007 ; 88: S1 - S19
7. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care. 2001 ; 24: 925-932 (Pubitemid 33636071)
8. Anderson M, Fritsche K. (Ω-3) Fatty acids and infectious disease resistance. J Nutr. 2002 ; 132: 3566-3576 (Pubitemid 35435030)
9. Buckley JD, Howe PR. Anti-obesity effects of long-chain omega-3 polyunsaturated fatty acids. Obes Rev. 2009 ; 10: 648-659
10. Lorgeril M, Renaud S, Salen P, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994 ; 343: 1454-1459 (Pubitemid 24176333)
11. Borkman M, Chisholm D, Furler S. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes. 1989 ; 38: 1314-1319 (Pubitemid 19247429)
12. Derosa G, Cicero AF, Fogari E, D'Angelo A, Bonaventura A, Maffioli P. Effects of Ω-3 PUFA on insulin resistance after an oral fat load. Eur J Lipid Sci Technol. 2011 ; 113: 1-11
13. Salmeron J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001 ; 73: 1019-1026 (Pubitemid 32496939)
14. Van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care. 2002 ; 25: 417-424 (Pubitemid 41103330)
15. Gibson RS Principles of Nutritional Assessment. New York: Oxford University Press ; 2005 :
16. Physical Status: The Use and Interpretation of Anthropometry. Geneva, Switzerland: WHO ; 1995 :
17. Obesity Prevention and Managing the Global Epidemic. Geneva, Switzerland: WHO ; 1998 :
18. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurement of the human body. Am J Clin Nutr. 1985 ; 41: 810-817 (Pubitemid 15092891)
19. McGowan MW, Artiss J, Strandbergh DR, Zak B. A peroxidase coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983 ; 29: 538-542 (Pubitemid 13160770)
20. Kostner GM, Avogaro P, Bom GB, Cazzolato G, Quinci GB. Determination of high-density lipoproteins screening methods compared. Clin Chem. 1979 ; 25: 939-942 (Pubitemid 9200944)
21. Lott JA, Turner K. Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem. 1975 ; 21: 1754-1760
22. Richmond W. Preparation and properties of cholesterol oxidase from Nocardia sp and its application to the dynamic assay of total cholesterol in serum. Clin Chem. 1973 ; 19: 1350-1356
23. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 ; 18: 499-502
24. Mathews DR, Hosker JP, Rudensk BA, Naylor DF, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 ; 28: 412-419 (Pubitemid 15018832)
25. Katz A, Nambi SS, Mather K, et al. Quantitative Insulin Sensitivity Check Index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000 ; 85: 2402-2410 (Pubitemid 32269192)
26. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998 ; 21: 518-524 (Pubitemid 28172927)
27. Crook MA. Type 2 diabetes mellitus: a disease of the innate immune system? An update. Diabetic Med. 2004 ; 21: 203-207
28. Després JP. Health consequences of visceral obesity. Ann Med. 2001 ; 8: 534-541 (Pubitemid 33052274)
29. Castro SH, Mato HJ, Gomes MB. Parĝmetros antropométricos e síndrome metabólica em diabetes tipo 2. Arq Bras Endocrinol. 2006 ; 50: 450-455 (Pubitemid 44298522)
30. Qio Q, Nyamdori R. Is the association of type II diabetes with waist circumference or waist-to-hip ratio stronger than that with body mass index?. Eur J Clin Nutr. 2009 ; 64: 30-34
31. Kabir M, Skurnik G, Naour N, et al. Treatment for 2 mo with Ω-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr. 2007 ; 86: 1670-1679 (Pubitemid 350232182)
32. Peyron-Caso E, Quignard-Boulangé A, Laromiguière M, et al. Dietary fish oil increases lipid mobilization but does not decrease lipid storage-related enzyme activities in adipose tissue of insulin-resistant, sucrose-fed rats. J Nutr. 2003 ; 133: 2239-2243 (Pubitemid 36841547)
33. Rillaerts EG, Engelmann GJ, Van Camp KM, De Leeuw I. Effect of omega-3 fatty acids in diet of type 1 diabetic subjects on lipid values and hemorheological parameters. Diabetes. 1989 ; 38: 1412-1416 (Pubitemid 19271723)
34. Holness MJ, Greenwood GK, Smith ND, Sugden MC. Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and the regulation of endogenous glucose production. Endocrinology. 2003 ; 144: 3958-3968 (Pubitemid 37088751)
35. Sirtori CR, Crepaldi G, Manzato E, et al. One year treatment with ethyl esters of Ω-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. Atherosclerosis. 1998 ; 137: 419-427 (Pubitemid 28215888)
36. Geloneze B, Gelonese SR, Ermetice MN, Repetto EM, Tambascia MA. The threshold value for insulin resistance (HOMA-IR) in an admixture population. IR in the Brazilian Metabolic Syndrome Study. Diabetes Res Clin Pr. 2006 ; 72: 219-220
37. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr. 1999 ; 70: 817-825 (Pubitemid 29512906)
38. Lovejoy JC. The influence of dietary fat on insulin resistance. Curr Diabetes Rep. 2002 ; 2: 435-440
39. Podolin DA, Gayles EC, Wei Y, Thresher JS, Pagliassotti MJ. Menhaden oil prevents but does not reverse sucrose-induced insulin resistance in rats. Am J Physiol. 1998 ; 274: 840-848
40. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science. 1987 ; 237: 885-888 (Pubitemid 17128276)
41. Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br J Nutr. 2000 ; 83: S59 - S66
42. Kris-Etherton PM, Harris WS, Appel LJ. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003 ; 23: 151-152 (Pubitemid 36231919)
43. West SG, Hecker KD, Mustad VA, et al. Acute effects of monounsaturated fatty acids with and without omega-3 fatty acids on vascular reactivity in individuals with type 2 diabetes. Diabetologia. 2005 ; 48: 113-122 (Pubitemid 40174663)
44. McEwen B, Morel-Kopp MC, Tofler G, Ward C. Effect of omega-3 fish oil on cardiovascular risk in diabetes. Diabetes Educ. 2010 ; 36 (4). 565-584
45. De Caterina R, Madonna R, Bertolotto A, Schmidt EB. Ω-3 Fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care. 2007 ; 30: 1012-1026 (Pubitemid 46556605)
46. Popp-Snijders C, Schouten JA, Heine RJ, Van der Meer J, Van der Veen EA. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res. 1987 ; 4: 141-147 (Pubitemid 17084024)
47. Annuzzi G, Rivellese A, Capaldo B, et al. A controlled study on the effects of Ω-3 fatty acids on lipid and glucose metabolism in non-independent diabetic patients. Atherosclerosis. 1991 ; 87: 65-73
48. Pelikánová T, Kohout M, Válek J, Kazdová L, Base J. Metabolic effects of omega-3 fatty acids in type 2 (non-insulin- dependent) diabetic patients. Ann N Y Acad Sci. 1993 ; 683: 272-278 (Pubitemid 23236677)
49. Axelrod L, Camuso J, Williams E, Kleinman K, Briones E, Schoenfeld D. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM: a randomized, prospective, double-blind, controlled study. Diabetes Care. 1994 ; 17: 37-44